Ariz Bio is a startup based in the United Kingdom, most recent round Series-c-plus, 1 tracked investor.
Ariz Bio is a company founded in 2024 headquartered in the United Kingdom. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Ariz Bio develops targeted cancer therapeutics by focusing on epigenetic changes in cancer cells, utilizing precision medicine approaches that combine biological and nanotechnologies to stop cancer at its root cause.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.